Cronos To Acquire 4 Redwood Subsidiaries, Expand Growth In US CBD Market


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Cronos Group Inc (NASDAQ:CRON) announced Friday it reached an agreement to acquire a CBD company with exposure to the United States.

What Happened

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Cronos entered into an agreement to acquire four of Redwood Holding Group's operating subsidiaries, the company said in a press release. Redwood is a maker and distributor of hemp-derived CBD-infused products for the skincare and other segments. The company's products include pure hemp oil that includes natural phytocannabinoids and terpenes found in the plant.

Redwood has exposure to the retail and hospitality space in the U.S. through its own brand called Lord Jones.

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!

Why It's Important

Redwood offers a best-in-class platform with hemp-based CBD formulations that "stand for quality and consistency," Cronos Chairman, President and CEO Mike Gorenstein said in the press release. Under Cronos' umbrella, the company can better address the notable demand for skincare and other consumer products which Redwood addresses.

"The inspiration for our company was simple, we wanted to create a brand we wished we could buy as adult consumers," said Robert Rosenheck, Redwood co-founder. "We chose Cronos Group because they share our vision and values and will help us continue our mission.

As part of the agreement, Cronos will pay around $300 million, net of Redwood's cash and debt of which $225 million will be paid in cash with the rest in newly issued Cronos stock. The deal remains subject to customary closing conditions and regulatory approvals and is expected to close in the third quarter of 2019.

Shares of Cronos traded higher by 4% at $13.25 in Friday's pre-market session.

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: CannabisM&ANewsMarketscannabinoidCBDMike Gorenstein